Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on August 6, 2021. The filing addresses the reconvening of the Company's previously adjourned 2021 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on corporate governance events and does not contain financial performance data.
Material Changes
There were no material changes to financial positions or business operations reported in this filing. The primary event is the procedural adjournment of the Annual Meeting due to a lack of quorum.
Outlook, Risks, and Unusual Items
- Meeting Adjournment: The Annual Meeting was adjourned because an insufficient number of shares were present or represented by proxy to constitute a quorum.
- Rescheduled Date: The meeting is reconvened for September 3, 2021, at 8:30 a.m. Pacific Time / 11:30 a.m. Eastern Time.
- Location: The reconvened meeting will be held at the Company's offices at 200 Pine Street, Suite 400, San Francisco, CA 94104.
- Proposals: No changes have been made to the proposals to be voted on by stockholders.
- Record Date: The record date remains April 12, 2021.
Key Facts for Investor Verification
- Verify the quorum status and voting results at the reconvened meeting on September 3, 2021.
- Review the definitive proxy statement (Schedule 14A) filed on April 13, 2021, for details on the specific proposals to be voted on.
- Confirm that no new proposals were added between the initial meeting date and the adjournment.